Wednesday Report: FDA Hearing 31st May 2019/ Cannabis-Derived Compounds

“The Food and Drug Administration is announcing a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds”

PUBLIC HEARING

Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public HearingMAY 31, 2019

On This Page


Date:May 31, 2019Time:May 31, 2019
08:00 AM EDT ā€“ 06:00 PM EDTLocation:White Oak Campus: The Great Room
The Great Room

10903 New Hampshire Ave
Bldg 31 Conference Center, The Great Room (Rm 1503) 
Silver Spring, MD 20993
United States
Organized By:Food and Drug Administration

Registration for in person attendance and/or to make a presentation/provide oral comments is now closed. Due to space limitations, no same day registration is available for this hearing.

Interested parties may view the hearing via webcast.  All meeting attendees and other interested parties are encouraged to submit information to the public docket FDA-2019-N-1482 by July 2, 2019.

Background:

The Food and Drug Administration is announcing a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. See the Federal Register notice for more information.

Webcast Information:

FDA will webcast this public hearing. Barring any technical difficulties, FDA plans to post a link to the recorded webcast after the hearing.

There are two links to view the webcast.

Submitting Comments:

FDA is establishing a docket for public comment on this hearing.The docket number is FDA-2019-N-1482. The docket will close on July 2, 2019. Submit either electronic or written comments on this public hearing by July 2, 2019. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before July 2, 2019.The Regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of July 2, 2019. Comments received by mail/ hand delivery/ courier (for written/ paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.


Event Materials

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.